Background Machine learning (ML) and deep learning (DL) methods have recently
garnered a great deal of attention in the field of cancer research by making a noticeable …

The deployment of machine learning for tasks relevant to complementing standard of care
and advancing tools for precision health has gained much attention in the clinical …

Abstract Currently, the International Prognostic Index (IPI) is the most used and reported
model for prognostication in patients with newly diagnosed diffuse large B-cell lymphoma …

Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoid malignancy
worldwide, comprising approximately 30% of all lymphomas. Currently, 50% to 60% of …

Diffuse large B cell lymphoma (DLBCL) is the most common hematological malignancy in
adults. Ferroptosis is an iron-dependent programmed cell death caused by lipid …

Massively parallel sequencing helps create new knowledge on genes, variants and their
association with disease phenotype. This important technological advancement …

Background Treatments are limited for patients with relapsed/refractory Diffuse large B-cell
lymphoma (DLBCL), and their survival rate is low. Prediction of the recurrence hazard for …

Efforts have been made to improve the risk stratification model for patients with diffuse large
B-cell lymphoma (DLBCL). This study aimed to evaluate the disease prognosis using …

As the main detoxification organ of human body, liver is very important in humans' health by
metabolizing a lot of substances that are taken in, including alcohol and the medicine …

Background This study aimed to explore the added prognostic value of baseline metabolic
volumetric parameters and cell of origin subtypes to the National Comprehensive Cancer …